Recursion Pharmaceuticals
RXRX
#4411
Rank
A$2.84 B
Marketcap
$9.75
Share price
1.27%
Change (1 day)
19.87%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: A$2.84 Billion

As of November 2024 Recursion Pharmaceuticals has a market cap of A$2.84 Billion. This makes Recursion Pharmaceuticals the world's 4411th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2024

End of year Market Cap

Year Marketcap Change
2024A$2.84 B-8.99%
2023A$3.12 B45.47%
2022A$2.14 B-46.21%
2021A$3.99 B

End of Day market cap according to different sources

On Nov 2nd, 2024 the market cap of Recursion Pharmaceuticals was reported to be:

A$2.84 Billion
by Yahoo Finance info icon info icon
A$2.84 Billion
by CompaniesMarketCap info icon info icon
A$2.74 Billion
by Nasdaq info icon info icon